Lead Plaintiff Deadline: January 2, 2026. The Dual Focus of the CarMax (KMX) Securities Fraud Suit The complaint highlights two central, undisclosed issues that allegedly led to the stock's inflation and ultimate collapse: Partner Reed Kathrein Urges KMX Investors to Contact Firm Before January 2, 2026 Lead Plaintiff Deadline SAN FRANCISCO, Dec. 15, 2025 /PRNewswire/ -- National investor rights law firm Hagens Berman reminds investors that the Lead Plaintiff Deadline in the securities class action lawsuit a ...

Core Viewpoint - A class action lawsuit has been filed against Smartsheet Inc. regarding its January 2025 sale to a consortium including Blackstone, Vista Equity Partners, and Platinum Falcon, alleging violations of federal securities laws [1][2]. Group 1: Lawsuit Details - The lawsuit seeks to recover damages for investors who purchased Smartsheet shares in connection with the January 2025 merger [2]. - Allegations include that defendants issued a misleading Schedule 14A Proxy Statement to solicit stockholder approval for the buyout [3]. - Defendants are accused of mischaracterizing Smartsheet's financial performance and using a financial metric created solely for the buyout approval [3]. - Mark P. Mader, a defendant, is claimed to have failed in his disclosure obligations, leading to materially false and misleading statements about Smartsheet's business [3]. Group 2: Next Steps for Investors - Investors who purchased shares in connection with the merger have until February 9, 2026, to request to be appointed as lead plaintiff in the class action [4]. - The law firm representing the investors operates on a contingency fee basis, meaning they will only recover costs if successful [5]. Group 3: Law Firm Background - Bronstein, Gewirtz & Grossman, LLC is a nationally recognized firm specializing in securities fraud class actions and has recovered hundreds of millions for investors [6]. - The firm emphasizes restoring investor capital and ensuring corporate accountability to maintain market integrity [6].

Core Viewpoint - A federal securities class action has been filed against Jayud Global Logistics Limited, alleging misleading statements and a "pump-and-dump" scheme involving its Class A ordinary shares during the class period from April 21, 2023, to April 30, 2025 [1][2]. Group 1: Legal Action Details - The class action was filed in the United States District Court for the Southern District of New York [1]. - Investors have until January 20, 2026, to seek appointment as lead plaintiff in the case [3]. Group 2: Allegations Against Jayud - The complaint alleges that Jayud and other defendants made materially false or misleading statements and failed to disclose adverse facts [2]. - The defendants are accused of orchestrating a "pump-and-dump" scheme, suggesting they were "uniquely situated" to engineer this activity involving Jayud's shares [2]. Group 3: Law Firm Background - Wolf Haldenstein Adler Freeman & Herz LLP, founded in 1888, has over 125 years of experience in securities litigation and aims to protect the rights of investors who have suffered financial harm [3].

Core Insights - The lawsuit against Starbucks alleges that the company and its former CEO made materially false or misleading statements regarding its "Triple Shot" reinvention strategy and revenue outlook for 2024 [3][5]. Group 1: Lawsuit Details - The lawsuit was filed by Charles Garbaccio on behalf of himself and other shareholders, claiming violations of federal securities law [3]. - The claims focus on the company's growth plan for China and the revenue outlook related to the "Triple Shot" strategy [5]. - A federal judge partially dismissed the case, ruling that shareholders had shown "some, but not all" of their securities fraud claims under section 10(b) of the Exchange Act [6]. Group 2: Recent Developments - A motion was granted to reconsider ex-CFO Rachel Ruggeri as a defendant in the lawsuit, reversing a previous dismissal of claims against her [7]. - The court found that the plaintiffs had adequately pleaded a § 10(b) claim, which allowed for the reconsideration of Ruggeri's role as a "controlling person" in the suit [7].

Core Viewpoint - Integer Holdings Corporation is facing a class action lawsuit for allegedly making false statements and failing to disclose critical information regarding its competitive position and sales performance in the electrophysiology market [3][4]. Group 1: Class Action Lawsuit Details - The class action lawsuit is titled West Palm Beach Firefighters' Pension Fund v. Integer Holdings Corporation and covers purchasers of Integer Holdings common stock from July 25, 2024, to October 22, 2025 [1]. - Investors have until February 9, 2026, to seek appointment as lead plaintiff in the lawsuit [1]. - The lawsuit alleges that Integer Holdings overstated its competitive position and mischaracterized its electrophysiology devices as growth drivers [3]. Group 2: Financial Performance and Impact - On October 23, 2025, Integer Holdings lowered its full-year 2025 sales guidance, which was below analysts' expectations [4]. - The company projected net sales growth of -2% to 2% and organic sales growth of 0% to 4% for the full year of 2026 [4]. - Following the announcement, the stock price of Integer Holdings fell by more than 32% [4]. Group 3: Company Background - Integer Holdings operates as a medical device contract development and manufacturing company [2]. - The firm is involved in the electrophysiology market, which is experiencing growth, but the company has faced challenges in maintaining its sales performance [3].

Core Viewpoint - The Gross Law Firm has issued a notice to shareholders of Avantor, Inc. regarding a class action lawsuit alleging that the company made materially false and misleading statements about its competitive positioning and business operations during the specified class period [1][2]. Summary by Relevant Sections Allegations - The complaint claims that during the class period from March 5, 2024, to October 28, 2025, Avantor's competitive positioning was weaker than publicly represented by the defendants [1]. - It is alleged that Avantor faced negative impacts from increased competition, which were not disclosed [1]. - As a result, the representations made by the defendants regarding the company's business, operations, and prospects were materially false and misleading, lacking a reasonable basis [1]. Class Action Details - Shareholders who purchased shares of AVTR during the class period are encouraged to register for the class action, with a deadline for lead plaintiff appointment set for December 29, 2025 [2]. - Registered shareholders will be enrolled in a portfolio monitoring software to receive updates throughout the case lifecycle [2]. Law Firm Background - The Gross Law Firm is a nationally recognized class action law firm dedicated to protecting the rights of investors affected by deceit, fraud, and illegal business practices [3]. - The firm aims to ensure companies adhere to responsible business practices and seeks recovery for investors who suffered losses due to misleading statements or omissions that inflated stock prices [3].

Core Insights - BellRing Brands, Inc. is under investigation for potential violations of federal securities laws, as announced by Bleichmar Fonti & Auld LLP [1] Company Overview - BellRing Brands operates in the convenient nutrition category, with primary brands including Premier Protein and Dymatize, which offer ready-to-drink protein shakes and powders [2] - The company reported that Premier Protein achieved an all-time high in household penetration and strong demand across all channels, driven by distribution expansion and promotional activity [2] Sales Growth Concerns - There are concerns that the sales growth during the relevant period may have been artificially inflated due to temporary trade inventory loading at key retailers, rather than sustainable consumer demand [2] Stock Performance - On May 5, 2025, BellRing disclosed that several key retailers reduced their weeks of supply, which would negatively impact Q3 2025 growth, leading to a stock price drop of $13.96 per share (over 18%) from $77.34 to $63.38 on May 6, 2025 [3] - On August 4, 2025, the company announced disappointing quarterly consumption of Premier Protein RTD Shakes, resulting in a stock price decline of $17.46 per share (nearly 33%) from $53.64 to $36.18 on August 5, 2025 [4]

NEW YORK, Dec. 15, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a class action lawsuit has been filed against Stride, Inc. (NYSE: LRN) and certain of the Company’s senior executives for securities fraud after significant stock drops resulting from the potential violations of the federal securities laws. If you invested in Stride, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/stride-inc-class-action-lawsuit. Inv ...

Core Viewpoint - A class action lawsuit has been filed against Inspire Medical Systems, Inc. and certain senior executives for securities fraud following a significant stock drop due to potential violations of federal securities laws [1]. Company Overview - Inspire Medical Systems develops and manufactures an implantable medical device for the treatment of sleep apnea, with the latest version being Inspire V, which received FDA approval on August 2, 2024 [4]. Lawsuit Details - The lawsuit claims are based on Sections 10(b) and 20(a) of the Securities Exchange Act of 1934, representing investors in Inspire stock. The case is pending in the U.S. District Court for the District of Minnesota [3]. Stock Performance - On August 4, 2025, Inspire disclosed that the launch of Inspire V would face an "elongated timeframe," leading to a reduction in 2025 earnings per share guidance by over 80%. This was attributed to undisclosed factors affecting the rollout and weak demand due to excess inventory of older devices [7][8]. Stock Price Impact - Following the announcement, Inspire's stock price dropped by $42.04 per share, or more than 32%, from $129.95 on August 4, 2025, to $87.91 on August 5, 2025 [8].

Core Viewpoint - A class action lawsuit has been filed against James Hardie Industries plc and certain senior executives for securities fraud following a significant stock drop due to potential violations of federal securities laws [1]. Group 1: Lawsuit Details - The lawsuit is pending in the U.S. District Court for the Northern District of Illinois, captioned Laborers' District Council and Contractors' Pension Fund of Ohio v. James Hardie Industries plc, et al., No. 1:25-cv-13018 [3]. - Investors have until December 23, 2025, to request to be appointed to lead the case [3]. Group 2: Company Background - James Hardie is a producer and marketer of high-performance fiber cement building solutions, primarily used in external siding for the residential building industry in the U.S. and Canada [4]. Group 3: Allegations of Fraud - The complaint alleges that James Hardie misrepresented the strength and momentum of its North American fiber cement segment, claiming sustainable customer demand when, in fact, sales were driven by inventory loading by channel partners [5]. - On August 19, 2025, the company disclosed a 12% decline in North American fiber cement sales, attributed to destocking efforts by customers, leading to a stock price drop of over 34% from $28.43 to $18.64 per share [6].